Arteris, Inc. (NASDAQ:AIP) VP Paul L. Alpern Sells 3,609 Shares

Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul L. Alpern sold 3,609 shares of the business's stock in a transaction on Thursday, July 3rd. The stock was sold at an average price of $9.25, for a total value of $33,383.25. Following the completion of the sale, the vice president directly owned 76,547 shares in the company, valued at $708,059.75. This trade represents a 4.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Arteris Stock Performance

Arteris stock traded up $0.26 during midday trading on Tuesday, hitting $9.55. 561,868 shares of the company's stock were exchanged, compared to its average volume of 231,136. The firm has a 50-day moving average of $8.06 and a two-hundred day moving average of $8.57. Arteris, Inc. has a 12 month low of $5.46 and a 12 month high of $12.64. The company has a market cap of $400.91 million, a PE ratio of -11.65 and a beta of 1.44.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently made changes to their positions in AIP. Quarry LP purchased a new position in Arteris during the fourth quarter worth approximately $46,000. US Bancorp DE raised its holdings in Arteris by 29.0% in the 4th quarter. US Bancorp DE now owns 5,702 shares of the company's stock valued at $58,000 after acquiring an additional 1,283 shares during the last quarter. CWM LLC lifted its position in Arteris by 4,810.1% during the first quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after buying an additional 10,005 shares in the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris in the first quarter valued at about $95,000. Finally, Strs Ohio purchased a new stake in shares of Arteris during the 1st quarter valued at approximately $104,000. Institutional investors and hedge funds own 64.36% of the company's stock.

Wall Street Analyst Weigh In

Separately, Rosenblatt Securities restated a "buy" rating and set a $14.00 target price on shares of Arteris in a research report on Wednesday, May 21st.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.